Parkinsons 10/2

Gain Therapeutics To Host Virtual Webinar on Results From Phase 1 Study and Design of Upcoming Phase 1b Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease

How artificial intelligence could monitor brain health and find dementia sooner

AI-Driven Wearable Tech Enables Silent Speech

AI-powered tech could help people with speech impairments to work remotely

Gain Therapeutics Presents Phase 1 GT-02287 Data at International Congress of Parkinson’s Disease and Movement Disorders Demonstrating Increase in GCase Activity in Healthy Volunteers

RBR50 Spotlight: PickGPT uses power of generative AI for robotics

Bookmarks | Amazon fell behind in AI. Now it’s racing to catch up

Listening to End Users Is Essential — Here’s How One Digital Health Startup Used Feedback to Revamp Its Platform

RBR50 Spotlight: Dexterity stacks AI, robotics for truck loading

How AI could monitor brain health and find dementia sooner

Wispr Raises $12M For New Flow Dictation Software Roll-Out

Metsera touts long-acting GLP-1 drug; Novartis strikes an AI deal